Questions surrounding coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) focus on ascertaining an individual's risk of being infected, present infection status, past infection, and sequalae of past infection.
- New loss of taste or smell
- New rash on fingers and toes
- New difficulty breathing
- Sore throat (upper respiratory infection, such as pharyngitis)
- New cough (lower respiratory infection)
- Unusual fatigue
- Fever above 100.0 F, or feeling feverish (chills, body aches) – influenza-like symptoms
- Vomiting or diarrhea (gastroenteritis)
- Loss of appetite
An affirmative answer to any of these questions should raise suspicion that the person is infected with SARS-CoV-2 and should result in a request for a COVID-19 test. The local prevalence of COVID-19 should be considered when assessing the likelihood that specific signs and symptoms are COVID-19 related. During a pandemic, COVID-19 cannot be ruled out based solely on signs and symptoms.
A person can be asymptomatic (infected with no signs or symptoms) or pre-symptomatic (infected with no signs or symptoms but will eventually develop signs or symptoms of COVID-19). Although no signs or symptoms may not be present, both asymptomatic and pre-symptomatic individuals should be considered infectious.
- If diagnosed, were you hospitalized?
- If hospitalized, for how long were you hospitalized and were you treated in an intensive care unit (ICU)?
- Since your diagnosis with COVID-19, have you had a negative COVID-19 test?
Depending on the severity of a past infection, the patient may be taking medications to prevent COVID-19 associated complications, such as using anticoagulants or antiplatelet medications to prevent venous thromboembolism (VTE).
- Shortness of breath at rest
- Chest pain
- Heart failure
- Venous thromboembolism
- Muscle weakness
- Postural orthostatic tachycardia
- Neuropathic pain and headache
- Chronic pain
- Cognitive changes
- Psychiatric illness
- Kidney impairment
- Hepatic impairment
After having recovered from the acute stage of COVID-19 some individuals may experience prolonged, and sometimes severe, residual health consequences (see above) known as “long COVID,” “post-acute COVID-19 syndrome”, “post-COVID syndrome”, “persistent post-COVID syndrome (PPCS) ,“ “chronic COVID syndrome.” Affected individuals are often referred to as “COVID long haulers.”
- When was the test performed?
- What type of test was performed (RT-PCR, antigen)
- What was the result of the test?
- What was the reason for being tested?
These questions would add to information regarding an individual’s COVID-19 status.
- Which vaccine?
- How many doses?
- When did you receive your last dose?
- Have you been tested for the presence of antibodies?
A COVID-19 vaccine is considered effective in mitigating severe illness and hospitalization 2 weeks after the last dose. An antibody test can reveal past infection, as well as response to a vaccine.
- Medical Disorders
- Oral Health Care Considerations
- Laboratory Values